US 11786601
Pegylated capsule-degrading enzyme for the treatment of anthrax
granted A61KA61K38/45A61K47/60
Quick answer
US patent 11786601 (Pegylated capsule-degrading enzyme for the treatment of anthrax) held by The Government of the United States of America, as represented by the Secretary of the Navy expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of America, as represented by the Secretary of the Navy
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/45, A61K47/60